Iridoviruses are a family of large, double-stranded DNA viruses that primarily infect invertebrates, including insects, crustaceans, and amphibians. The name "Iridovirus" is derived from the iridescent appearance of infected tissues under a microscope due to the presence of crystalline arrays of virions. These viruses are classified into two genera: Iridovirus and Chloriridovirus. They possess icosahedral symmetry and exhibit a complex structure with an outer lipid envelope, an icosahedral protein capsid, and an inner core containing the viral genome. Iridovirus infections can have significant ecological and economic implications, particularly in aquaculture, where they can cause mass mortalities in farmed fish and shrimp. The viruses are highly resistant to environmental conditions, contributing to their persistence in aquatic environments. Research on iridoviruses extends beyond their pathogenicity, with investigations into their molecular biology, genome structure, and potential applications in biotechnology. Understanding iridovirus interactions with their hosts is essential for developing strategies to mitigate their impact on aquaculture and ecosystems.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey